10-122980519-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001363531.2(PSTK):c.40G>A(p.Gly14Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,456,336 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001363531.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSTK | NM_001363531.2 | c.40G>A | p.Gly14Arg | missense_variant | 1/6 | ENST00000406217.8 | NP_001350460.1 | |
PSTK | NM_153336.3 | c.40G>A | p.Gly14Arg | missense_variant | 1/7 | NP_699167.2 | ||
PSTK | XM_017015641.3 | c.40G>A | p.Gly14Arg | missense_variant | 1/4 | XP_016871130.1 | ||
PSTK | XR_001747018.2 | n.119G>A | non_coding_transcript_exon_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSTK | ENST00000406217.8 | c.40G>A | p.Gly14Arg | missense_variant | 1/6 | 5 | NM_001363531.2 | ENSP00000384653 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000293 AC: 7AN: 239216Hom.: 0 AF XY: 0.0000380 AC XY: 5AN XY: 131466
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1456336Hom.: 1 Cov.: 32 AF XY: 0.0000304 AC XY: 22AN XY: 724544
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2023 | The c.40G>A (p.G14R) alteration is located in exon 1 (coding exon 1) of the PSTK gene. This alteration results from a G to A substitution at nucleotide position 40, causing the glycine (G) at amino acid position 14 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at